The UK Biobank data exposure highlights a growing risk in modern health research: sensitive data is not only vulnerable to breaches, but to systemic leakage through normal scientific practices. This raises urgent...read more
Features and insights
From Surveys to Signals: How AI Is Changing Voice of the Customer in Life Sciences
From Surveys to Signals: How AI Is Changing Voice of the Customer in Life Sciences I’ve been spending some time thinking on how Voice of the Customer (VoC) programs are evolving as artificial intelligence (AI) becomes...read more
From Experimentation to Execution: How 2025 Reset the Trajectory of Healthcare and What 2026 Will Demand
TL;DR 2025 shifted healthcare from experimentation to execution AI moved from tools to infrastructure 2026 will reward disciplined execution over vision Why this matters for precision medicine + generative AI This...read more
Inside the Biology of 116 Years of Life: What Multiomics Reveals About Extreme Longevity
At enlightenbio, we are deeply committed to studying longevity and health span, which aligns with our personal and professional interests in biological science. For more on this, please see a couple of earlier...read more
Stop Guessing. Start Diagnosing: The Marketing & Product-Market Fit Scorecard
I recently conducted a LinkedIn survey to understand why most startups fail. I asked “Most startups don’t fail because of a bad idea — they fail because founders ignore the warning signs. I’m curious — which of these do...read more
BEVIMI Launches: A New Bid to Bring Pharma-Grade Rigor to Brain Health
This past week, BEVIMI was officially announced. This new company aims to bring pharmaceutical-style rigor to the consumer brain-health market. Headquartered in Greenwich, Connecticut and led by co-founders Paul...read more
Strong Grip, Strong Future: A Key Predictor of Healthy Aging
And why your handshake may reveal more about your health than your blood pressure Indicators of Long-Term Health and Longevity In this next longevity blog, I’m excited to delve into phenotypic biomarkers of healthy...read more
The Critical Link Between CROs and Sponsors: Making Data Work for You
Maximizing Focus, Minimizing Cost: The Strategic Logic of CRO Engagement Outsourcing to Contract Research Organizations (CROs) has been a fundamental practice in therapeutic and device discovery and early development...read more
It’s Not the Quantity but the Quality of Data That Enables AI/ML-Based Bioprocess Applications
Over the past 30 years, product titers have increased by almost 20% year over year (Langer and Rader, 2015). Since the 1990s, this has translated into dramatic increases in production, from an average of <1g/L to...read more
Neither AI nor ChatGPT Will Save Your Drug Discovery Pipeline …
AI is having a tough time generalizing molecule structures when your data is more scarce than the complexity of your problem allows for “Boring is good” is the mantra of successful engineering. This is in contrast to...read more
